Growth Metrics

Resmed (RMD) Change in Accured Expenses (2016 - 2025)

Resmed's Change in Accured Expenses history spans 17 years, with the latest figure at $10.6 million for Q4 2025.

  • For Q4 2025, Change in Accured Expenses rose 152.25% year-over-year to $10.6 million; the TTM value through Dec 2025 reached $130.5 million, down 4.25%, while the annual FY2025 figure was $91.0 million, 25.49% down from the prior year.
  • Change in Accured Expenses reached $10.6 million in Q4 2025 per RMD's latest filing, up from $7.6 million in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $257.5 million in Q1 2021 to a low of -$293.3 million in Q3 2021.
  • Average Change in Accured Expenses over 5 years is $16.3 million, with a median of $9.3 million recorded in 2022.
  • The largest YoY upside for Change in Accured Expenses was 36862.42% in 2024 against a maximum downside of 2399.02% in 2024.
  • A 5-year view of Change in Accured Expenses shows it stood at -$12.4 million in 2021, then plummeted by 39.38% to -$17.3 million in 2022, then tumbled by 99.02% to -$34.4 million in 2023, then surged by 112.28% to $4.2 million in 2024, then skyrocketed by 152.25% to $10.6 million in 2025.
  • Per Business Quant, the three most recent readings for RMD's Change in Accured Expenses are $10.6 million (Q4 2025), $7.6 million (Q3 2025), and $49.1 million (Q2 2025).